chemistry3 papersavg year 2026weak evidence

The evaluation of the in vivo efficacy of the most potent compounds

Research gap analysis derived from 3 chemistry papers in our local library.

The gap

The evaluation of the in vivo efficacy of the most potent compounds. The investigation of the potential side effects and toxicity of these compounds. The development of novel compounds with improved inhibitory activities and selectivity.

Evidence profile

Sourced from the conclusions and future-work section of the source papers, classified as general, spanning 3 journals.

Research trend

Established — well-defined area with open sub-problems.

Supporting evidence — 3 representative gaps

  • Synthesis, in-vitro and in-silico bioactivity and computational studies of pyrene and p-methoxycinnamaldehyde linked 4-hydroxycoumarins (2026) · Scientific Reports · doi

    Future studies should examine the toxicity, metabolic ARTICLE IN PRESS ARTICLE IN PRESS ACCEPTED MANUSCRIPT stability, and effectiveness of both derivatives in living organisms, and also explore further modifications to improve the drug's absorption, strength, and selectivity.

    generalconclusions
    Keywords: article press future examine toxicity metabolic accepted manuscript stability effectiveness derivatives living organisms explore further
  • Design, Synthesis and Characterization of Novel Phenobarbitone derivatives for CNS activity by In Silico model (2026) · International Journal of Drug Delivery Technology · doi

    Further in vivo studies are needed to confirm the efficacy of the compounds. The study suggests the need for more research on the long-term efficacy of the compounds. The study highlights the importance of evaluating the safety and toxicity of the compounds.

    generalfuture-work sectionevidence 5/5
    Keywords: further vivo studies needed confirm efficacy compounds study
  • Synthesis and inhibitory activity of novel N-phenethylpiperidinehydrazide hydrazones against acetylcholinesterase, butyrylcholinesterase, and β-Amyloid (1–42) as potential anti-Alzheimer agents (2026) · Bioorganic and Medicinal Chemistry Reports · doi

    The evaluation of the in vivo efficacy of the most potent compounds. The investigation of the potential side effects and toxicity of these compounds. The development of novel compounds with improved inhibitory activities and selectivity.

    generalfuture-work sectionevidence 5/5
    Keywords: evaluation vivo efficacy potent compounds investigation potential side

Questions about this gap

The evaluation of the in vivo efficacy of the most potent compounds. The investigation of the potential side effects and toxicity of these compounds. The development of novel compo… This is supported by 3 representative gap statements extracted from 3 papers, rated weak evidence.

Explore this gap further

Run this gap as a query across open scholarly engines for the latest related literature.

Working on this gap? Review it with us.

AI Review reads your manuscript in one pass with 8 specialist agents, calibrated on 69K+ real peer reviews.

Related gaps in Chemistry

Command palette

Jump anywhere, run any action.